However, as has been found in other aspects, such as in tumor research, the rs1054135G>A mutation in the 3′UTR of the FABP4 gene in triple-negative breast cancer may lead to the enhanced binding of miR-3685 complementary to rs1054135, thereby inhibiting FABP4 gene expression and reducing fat synthesis [69,70]. The gene discussed is FABP4; the disease is neoplasm.